Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€2.79
10.09.21
€12.00
-
10.09.21

Could be worthwhile Investment >10% per year
Inventiva SA

Start price
Target price
Perf. (%)
€2.79
10.09.21
€8.00
-
10.09.21

Could be worthwhile Investment >10% per year
Poxel S.A.

Start price
Target price
Perf. (%)
€6.46
06.09.21
€5.00
06.09.22
-9.30%
07.10.21

Could be worthwhile Investment >10% per year
Valneva SE

Start price
Target price
Perf. (%)
€20.78
06.09.21
-
06.09.22
-39.56%
13.09.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€20.60
05.09.21
-
05.09.22
-43.93%
19.09.21

buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
04.09.21
€2.00
04.09.22
37.71%
18.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Innate Pharma

Start price
Target price
Perf. (%)
€6.20
03.09.21
-
03.09.22
-25.29%
06.09.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€20.18
03.09.21
€30.00
03.09.22
-59.38%
03.09.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business
buy
Advicenne

Start price
Target price
Perf. (%)
€7.78
31.08.21
€10.00
30.05.22
-6.94%
17.10.21

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€2.01
31.08.21
€10.00
30.05.22
-
31.08.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€13.84
25.08.21
-
25.08.22
-32.23%
26.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€5.10
30.07.21
-
30.07.22
2.55%
08.08.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.24
20.07.21
€20.00
20.07.22
116.90%
25.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
Valneva SE

Start price
Target price
Perf. (%)
€14.89
03.05.21
-
03.05.22
-24.78%
20.09.21

Virbac S.A.

Start price
Target price
Perf. (%)
€275.00
28.04.21
€270.00
28.04.22
43.82%
25.10.21

Could be worthwhile Investment >10% per year
buy
Adocia

Start price
Target price
Perf. (%)
€9.09
26.04.21
-
26.04.22
1.54%
09.08.21

buy
Valneva SE

Start price
Target price
Perf. (%)
€13.02
19.04.21
-
19.04.22
14.36%
03.05.21

Virbac S.A.

Start price
Target price
Perf. (%)
€279.00
19.04.21
-
19.04.22
35.48%
20.04.22

Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€5.98
17.04.21
€2.00
17.04.22
1.00%
01.05.21